FibroGen(FGEN) - 2023 Q4 - Earnings Call Presentation

| --- | --- | |-------------------------------------------------------------------------|---------------------------------------| | | | | Pancreatic tumor preclinical models demonstrate that CTGF: | Pamrevlumab has multiple effects in | | • Promotes proliferation | pancreatic cancer preclinical models: | | • Decreases apoptosis and promotes survival | • Increased survival | | • Supports invasion | • Promoted tumor cell apoptosis | | • Stimulates fibroblast activation, proliferation, and ECM deposition | • R ...